Global Peanut Allergy Treatment Market research to Witness Increased Revenue Gro

Posted by Rashi Pande on November 12th, 2019

Global Peanut Allergy Treatment Market By Drug Type (Injectable Epinephrine, Antihistamines), Route of Administration (Oral, Injectable), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Peanut Allergy Treatment Market

The peanut allergy treatment market is expected to register a substantial CAGR in the forecast period of 2019 to 2026. The upcoming market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.  Ongoing clinical trials for the launch of innovative products has promised a better future for the market

Market Definition: Global Peanut Allergy Treatment Market

There are many food allergies worldwide, in which most common is the peanut allergy.  It can cause several allergic reactions including anaphylaxis. This type allergy is found in all age group but majorly found in the children. Experimental drugs are used for the treatment of this peanut allergy as there is no available treatment in the market.

According to the study of American College of Allergy, Asthma & Immunology in 2017 the peanut allergies are increased by 21.0% from 2010, which makes around 2.5% children in U.S. allergic to peanut.

Market Drivers:

• Government initiatives towards creating awareness and regulatory approvals will drive this market growth
• Prevailing number of clinic visit for allergy related treatments also acts as a market driver
• Introduction of new products for the treatment of peanut allergies are boosting the market growth
• Investment in R&D of novel products by the companies are propelling the future of the market

Market Restraints:

• Stringent regulation for the product approval hampers the market growth
• Treatments such as oral immunotherapy and epinephrine treatment has not approved in the market which is restraining the market growth
• Lack of skilled professional is another factor restricting the market growth

Key Development in the Market:

• In March 2019, FDA launched its review on the product of Aimmune Therapeutics, AR101. It is a peanut oral immunotherapy drug which had cleared all the clinical trials successfully. The acceptance of biologics license application (BLA) by FDA will prove beneficial for the company as well as for the patients suffering with peanut allergies

Competitive Analysis

Global peanut allergy treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of peanut allergy treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Major Market Competitors/Players

Few of the major competitors currently working in the global peanut allergy treatment market are Mylan N.V., Sanofi,  Pfizer Inc., kaleo, Inc., DBV Technologies, Aimmune Therapeutics., Prota Therapeutics Pty Ltd, Cambridge Peanut Allergy Clinic, Regeneron, ANAPTYSBIO, INC., ALK, Stallergenes Greer,  Astellas Pharma Inc.,  Immunomic Therapeutics, Inc, HAL Allergy B.V., Aravax among others.